Silence Therapeutics plc total revenue, net income and dynamics of changes in Euro today
The dynamics of Silence Therapeutics plc net revenue grew by 0 € compared to the previous report. The dynamics of net income of Silence Therapeutics plc has changed by 0 € in recent years. Here are the main financial indicators of Silence Therapeutics plc. The financial graph of Silence Therapeutics plc displays the online status: net income, net revenue, total assets. Silence Therapeutics plc financial report on the graph shows the dynamics of assets. A graph of the value of all Silence Therapeutics plc assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
3 390 234.91 €
-
-11 628 302.72 €
-
31/03/2021
3 390 234.91 €
-
-11 628 302.72 €
-
31/12/2020
2 513 240.01 €
-
-12 480 936.65 €
-
30/09/2020
2 513 240.01 €
-
-12 480 936.65 €
-
30/06/2019
0 €
-
-4 761 989.49 €
-
31/03/2019
0 €
-
-4 761 989.49 €
-
31/12/2018
0 €
-
-5 640 144.44 €
-
30/09/2018
0 €
-
-5 640 144.44 €
-
Show:
to
Silence Therapeutics plc financial report charts
The latest dates of Silence Therapeutics plc financial statements available online: 30/09/2018, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Silence Therapeutics plc is 30/06/2021. Gross profit Silence Therapeutics plc is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Silence Therapeutics plc is 1 241 500 €
Silence Therapeutics plc quarterly report dates
Cost of revenue Silence Therapeutics plc is the total cost of producing and distributing of products and services of a company. Cost of revenue Silence Therapeutics plc is 1 681 000 € Total revenue Silence Therapeutics plc refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Silence Therapeutics plc is 2 922 500 € Operating income Silence Therapeutics plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Silence Therapeutics plc is -11 134 000 €
Net income Silence Therapeutics plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Silence Therapeutics plc is -10 024 000 € Current assets Silence Therapeutics plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Silence Therapeutics plc is 91 346 000 € Total assets Silence Therapeutics plc refers to the total amount of assets owned by a person or entity. Total assets Silence Therapeutics plc is 100 725 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 440 197.31 €
1 440 197.31 €
6 235 248.12 €
6 235 248.12 €
-
-
-2 628 084.58 €
-2 628 084.58 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 950 037.60 €
1 950 037.60 €
-3 722 008.11 €
-3 722 008.11 €
-
-
2 628 084.58 €
2 628 084.58 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 390 234.91 €
3 390 234.91 €
2 513 240.01 €
2 513 240.01 €
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-12 915 953.96 €
-12 915 953.96 €
-9 738 587.52 €
-9 738 587.52 €
-5 630 864.07 €
-5 630 864.07 €
-6 193 486.45 €
-6 193 486.45 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-11 628 302.72 €
-11 628 302.72 €
-12 480 936.65 €
-12 480 936.65 €
-4 761 989.49 €
-4 761 989.49 €
-5 640 144.44 €
-5 640 144.44 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
9 062 860.63 €
9 062 860.63 €
11 721 686.43 €
11 721 686.43 €
2 931 436.65 €
2 931 436.65 €
2 931 436.65 €
2 931 436.65 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
16 306 188.86 €
16 306 188.86 €
12 251 827.53 €
12 251 827.53 €
5 630 864.07 €
5 630 864.07 €
6 193 486.45 €
6 193 486.45 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
105 965 576.63 €
105 965 576.63 €
88 626 366.66 €
88 626 366.66 €
24 074 437.98 €
24 074 437.98 €
34 219 041.66 €
34 219 041.66 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
116 845 649.58 €
116 845 649.58 €
99 730 328.52 €
99 730 328.52 €
34 823 425.71 €
34 823 425.71 €
45 108 394.97 €
45 108 394.97 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
82 639 368.42 €
82 639 368.42 €
31 842 107.08 €
31 842 107.08 €
13 353 291.36 €
13 353 291.36 €
24 934 032.19 €
24 934 032.19 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
3 316 571.97 €
3 316 571.97 €
4 442 976.80 €
4 442 976.80 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
3 316 571.97 €
3 316 571.97 €
4 442 976.80 €
4 442 976.80 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
9.52 %
9.52 %
9.85 %
9.85 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
27 454 812.49 €
27 454 812.49 €
10 508 858.17 €
10 508 858.17 €
31 506 853.74 €
31 506 853.74 €
40 665 418.18 €
40 665 418.18 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-5 946 396.62 €
-5 946 396.62 €
-4 634 964.44 €
-4 634 964.44 €
Last revenue report of Silence Therapeutics plc was 30/06/2021. According to last financial report total revenue in Silence Therapeutics plc was 3 390 234.91 Euro and changed by 0% since last year. Net income in Silence Therapeutics plc was -11 628 302.72 € in last quartal, net income changes to 0%.
Current cash Silence Therapeutics plc - the sum of all of the cash a company has on the date of report. Current cash Silence Therapeutics plc is 71 238 000 €
